SSRI use and clinical outcomes in epithelial ovarian cancer Article

Christensen, Desire K, Armaiz-Pena, Guillermo N, Ramirez, Edgardo et al. (2016). SSRI use and clinical outcomes in epithelial ovarian cancer . 7(22), 33179-33191. 10.18632/oncotarget.8891

Open Access

cited authors

  • Christensen, Desire K; Armaiz-Pena, Guillermo N; Ramirez, Edgardo; Matsuo, Koji; Zimmerman, Bridget; Zand, Behrouz; Shinn, Eileen; Goodheart, Michael J; Bender, David; Thaker, Premal H; Ahmed, Amina; Penedo, Frank J; DeGeest, Koen; Mendez, Luis; Domann, Frederick; Sood, Anil K; Lutgendorf, Susan K

sustainable development goals

authors

publication date

  • May 31, 2016

webpage

keywords

  • ANTIDEPRESSANTS
  • CARCINOMA
  • CELLS
  • Cell Biology
  • DEPRESSION
  • Life Sciences & Biomedicine
  • MEDICATION USE
  • Oncology
  • RISK
  • SEROTONIN
  • SOLID TUMORS
  • Science & Technology
  • TAMOXIFEN
  • UNITED-STATES
  • cell proliferation
  • epithelial ovarian cancer
  • progression
  • selective serotonin reuptake inhibitors
  • serotonin

Digital Object Identifier (DOI)

publisher

  • IMPACT JOURNALS LLC

start page

  • 33179

end page

  • 33191

volume

  • 7

issue

  • 22